A recent study published in Nature Communications explored the association of COVID-19 with long-term allergic conditions. Study: Incident allergic diseases in post-COVID-19 condition: multinational ...

Social media claims linking Pfizer’s Covid-19 vaccine to hantavirus infection are misleading. A fact-check shows that the ...

Pew Research Center conducted this study to understand Americans’ views of the coronavirus and COVID-19 vaccines. For this analysis, we surveyed 10,133 U.S. adults from Feb. 7 to 11, 2024. Everyone ...

A pharmacy advertises the COVID-19 vaccine in March 2025 in New York City. Health correspondent As COVID-19 continues to circulate, questions remain about how to protect yourself in 2025. Should you ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The world was transformed by the emergence of SARS-CoV-2, the ...

Since the earliest days of the pandemic, health officials have gauged the threat of COVID-19 by comparing it to the flu. At first, it wasn’t even close. People hospitalized in 2020 with the then-novel ...

COVID-19 viral activity was high in the United States during the first week of September, according to fresh data from the Centers for Disease Control and Prevention. Some regions of the United States ...

Senior Correspondent Even relatively easy bouts with COVID-19 can still take a toll on the immune system, according to a paper published Mar. 15 in the journal Immunity—particularly on T-cells, which ...

Since May, highly contagious "FLiRT" coronavirus variants – a term for new mutations of Omicron – have been driving a rise in infections and emergency room trips. Virus levels at local wastewater ...

After the U.S. Food and Drug Administration (FDA) approved the emergency use of the 2024-2025 COVID-19 vaccines many questions are beginning to circulate. In the FDA's press release on Aug. 22, the ...